Acquisition - January 18, 2021
OssDsign completes acquisition of bone graft company Sirakoss
OssDsign has completed the acquisition of Sirakoss. The transaction was announced on November 3, 2020. USD 11 million OssDsign has acquired all outstanding Sirakoss shares in an all-cash transaction. The purchase price of USD 11 million, not including agreed milestone and royalty payments, is divided into three cash instalments, of which the first USD 5 […]
In a new job - November 16, 2020
OssDsign’s CFO leaves the company
OssDsign announces that its CFO Claes Lindblad is leaving the company in order to pursue other opportunities. A leading international recruitment firm has been engaged to lead the search process for a new CFO states OssDsign. Anders Svensson will take up the position as interim CFO as of Monday November 16, 2020. Svensson has previous […]
Financing - May 27, 2019
OssDsign finish a new issue of 151.3 MSEK before listing on Nasdaq First North
With this new issue of shares OssDsign adds about 151.3 million SEK and around 2000 new owners. “It is of course very gratifying to see a great interest in OssDsign and that we have been able to both attract well renowned institutional owners and achieve a broad dispersion in our offer. The new issue of […]
Agreement - February 6, 2017
OssDsign announces new agreement
OssDsign has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market. OssDsign recently announced FDA 510(k) clearance of OSSDSIGN Cranial PSI, a patient-specific medical implant intended for reconstruction of cranial defects. Matador Medical was founded and is led by Paul Byerley, who was previously senior vice president […]
MedTech Business - January 24, 2017
OssDsign announces FDA clearance
OssDsign has received 510(k) clearance by the US FDA for marketing of OSSDSIGN Cranial PSI in the USA. “Receiving FDA clearance for our flagship product OSSDSIGN Cranial is extremely positive news. This means we can continue working according to our existing plan of launching OSSDSIGN Cranial on the US market in Q1 2017. We are […]
Collaboration - January 16, 2017
OssDsign announces new European partnership for commercialization
Karolinska Development announces that portfolio company OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands. OssDsign’s lead products – OSSDSIGN Cranial and OSSDSIGN Facial – are already on sale […]
